Press Release: Mainstay Medical : Mainstay Medical Announces Commercial Launch of ReActiv8 in Australia

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc ("Mainstay" or the "Company") today announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back pain. "Launching ReActiv8, our Restorative Neurostimulation therapy, commercially in Australia is a significant milestone for our global commercial expansion. Several top Australian physicians have been part of our clinical studies since inception and are among the most experienced